-
Brazil: 10 years of a Compulsory License on HIV drug Efavirenz
NewsSymposium in Curitiba highlights the need for a collective fight to make medicines affordable. When governments are unreceptive, it is...
Read more about Brazil: 10 years of a Compulsory License on HIV drug Efavirenz
-
Patients demand AbbVie’s price bubble is burst – key HIV drug out of reach
Call to action NewsAbbVie’s monopoly has hiked prices – it’s time to burst the bubble and get prices back down to earth. Activists...
Read more about Patients demand AbbVie’s price bubble is burst – key HIV drug out of reach
-
Malaysia paves the way for compulsory licensing on hepatitis C medicines
NewsHistoric decision will cure more hepatitis C patients – and other countries can follow suit. Today, 20 September 2017, Malaysia’s...
Read more about Malaysia paves the way for compulsory licensing on hepatitis C medicines
-
Online access: Training course on reducing barriers to medicines in Africa
NewsMaking intellectual property issues easier to understand, to increase access to medicines – and you can apply now! An online...
Read more about Online access: Training course on reducing barriers to medicines in Africa
-
Tackling the hepatitis C epidemic in Malaysia
NewsWith new, revolutionary, drugs available, why isn’t everyone getting the cure? An estimated 454,000 people are living with hepatitis C...
Read more about Tackling the hepatitis C epidemic in Malaysia
-
An important step towards affordable TAF in Ukraine
NewsGilead adds TAF, a drug used in HIV and Hepatitis B treatment, to the Medicines Patent Pool for Ukraine. It...
Read more about An important step towards affordable TAF in Ukraine
-
IAS 2017: Closing ceremony exposes Gilead Sciences
NewsConference funders, Gilead Sciences, named and shamed for its “insatiable greed” Yesterday, the 9th International AIDS Conference on HIV Science...
Read more about IAS 2017: Closing ceremony exposes Gilead Sciences
-
A victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on atazanavir to Egypt
NewsDuring the 9th International AIDS Conference (23-26 July 2017), Bristol-Myers Squibb (BMS) and the Medicines Patent Pool (MPP) announced the...
-
HIV activists denounce ViiV for denying 3.5 million people access to optimal treatment
NewsToday, Monday, 24 July 2017, during the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), HIV treatment...
-
Intellectual Property Group opposes a resolution which would restrict access to medicines in Brazil
NewsOur partner in Brazil highlights the facts in a debate full of confusion. Last month, the Working Group on Intellectual...